emerging treatment options for refractory immune thrombocytopenia
Published 4 months ago • 130 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:29
novel promising agents for the treatment of itp
-
3:23
session overview: improving treatment for patients with itp
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
2:03
unmet needs in immune thrombocytopenia
-
4:02
toughest cases in itp | refractory itp | latest developments in itp treatment | dr karuna kumar
-
5:56
living with itp: marie louise's story
-
6:59
itp treatment selection criteria and treatment goals
-
2:06
current unmet needs in itp: impaired quality of life & chronic disorders
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
2:53
emerging treatment options for hsct-tma
-
1:47
treatment options for penta-refractory multiple myeloma
-
1:24
recent advances in the treatment and management of itp
-
2:55
current and emerging treatments for mf: an update from ash 2023
-
2:38
the management of itp during and after the covid-19 pandemic
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:10
the sensitization of immune checkpoint inhibitors with subsequent chemotherapy in r/r hl
-
1:53
avatrombopag: a novel oral therapy for the treatment of itp
-
1:51
checkpoint inhibition in the treatment of mpns
-
3:07
advice for community hematologists when prescribing bispecific antibodies for multiple myeloma
-
2:56
novel drugs for myeloma thromboprophylaxis